$PDPR targets massive #cannabis #hemp #cbd wellnes
Post# of 97987
(Total Views: 178)
Posted On: 02/14/2019 9:13:52 AM
$PDPR targets massive #cannabis #hemp #cbd wellness marketplace news:
https://finance.yahoo.com/news/marathon-group...00096.html
Marathon Group Enters The Rapidly Growing Cannabis And Hemp CBD Wellness Industry With A Newly Formed Wholly Owned Subsidiary MarathonRx, Inc.
GlobeNewswire•February 13, 2019
WATERBURY, CT, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Marathon Group Corp. (OTC PDPR) (the “Company” or “Marathon”) is pleased to announce the formation of their new subsidiary MarathonRx, Inc.
Marathon has extensive experience in the retail and online technology markets. As a result, a move to expand their services into the CBD wellness marketplace will help both small and large companies deal with the complexities of the unique cannabis industry.
The CBD market is extensive, ranging from medical uses to supplements to edibles. In addition to the benefits to humans, there is a huge market for animal and pet use of CBD products. As a result of the wide ranging uses of CBD products, the size of the hemp CBD market alone is projected to reach $22 billion dollars per year in consumer sales by 2022.
This exponential growth will need to be serviced by specialized technological solutions. Research reports from various industry experts, including Deloitte, Brightfield Group and others, indicate the CBD market could outpace and outgrow the marijuana market in the next few years. Marathon's expertise in point-of-sale solutions, e-commerce, advertising, digital marketing and more, is a perfect fit for providing these solutions.
“We are very excited about the formation of MarathonRx. Our ability to rapidly scale our technology from small to large businesses will facilitate strong growth of our subsidiary. Additionally, we can tailor our technology to meet the specific needs of the dynamic cannabis industry,” stated MacDonald Tudeme, President and CEO of Marathon.
MarathonRx’s mission is to deliver the highest quality products and services to capture a piece of an industry that is projected to be worth over $100 billion by 2025 in the US and $146 billion worldwide.
MarathonRx has laid the groundwork for a rapid move into the CBD field. Discussions are already underway with various labs and suppliers of top quality CBD products. You can stay up to date with our progress by visiting our website: http://www.marathonrx.com and subscribing to our newsletter for updates.
About MarathonRx, Inc.
MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry. As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.
About Marathon Group Corp
Marathon Group Corp. (PDPR) is a Connecticut-based software company engaged in web property development, focused on solving problems faced by small and medium size businesses.
Safe Harbor Statement
The matters discussed, particularly information regarding future revenue, earnings, business plans and goals, consist of forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections and involve risks and uncertainties, which could cause actual results to differ materially from the forward-looking information. Such statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management’s assumptions and the Company’s future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially. The Company undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking information contained herein is subject to the risk factors and uncertainties described in the Company’s filings with the Securities and Exchange Commission, which risk factors and uncertainties are incorporated by reference as though fully set forth herein.
MacDonald Tudeme
jasmactt@gmail.com
https://finance.yahoo.com/news/marathon-group...00096.html
Marathon Group Enters The Rapidly Growing Cannabis And Hemp CBD Wellness Industry With A Newly Formed Wholly Owned Subsidiary MarathonRx, Inc.
GlobeNewswire•February 13, 2019
WATERBURY, CT, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Marathon Group Corp. (OTC PDPR) (the “Company” or “Marathon”) is pleased to announce the formation of their new subsidiary MarathonRx, Inc.
Marathon has extensive experience in the retail and online technology markets. As a result, a move to expand their services into the CBD wellness marketplace will help both small and large companies deal with the complexities of the unique cannabis industry.
The CBD market is extensive, ranging from medical uses to supplements to edibles. In addition to the benefits to humans, there is a huge market for animal and pet use of CBD products. As a result of the wide ranging uses of CBD products, the size of the hemp CBD market alone is projected to reach $22 billion dollars per year in consumer sales by 2022.
This exponential growth will need to be serviced by specialized technological solutions. Research reports from various industry experts, including Deloitte, Brightfield Group and others, indicate the CBD market could outpace and outgrow the marijuana market in the next few years. Marathon's expertise in point-of-sale solutions, e-commerce, advertising, digital marketing and more, is a perfect fit for providing these solutions.
“We are very excited about the formation of MarathonRx. Our ability to rapidly scale our technology from small to large businesses will facilitate strong growth of our subsidiary. Additionally, we can tailor our technology to meet the specific needs of the dynamic cannabis industry,” stated MacDonald Tudeme, President and CEO of Marathon.
MarathonRx’s mission is to deliver the highest quality products and services to capture a piece of an industry that is projected to be worth over $100 billion by 2025 in the US and $146 billion worldwide.
MarathonRx has laid the groundwork for a rapid move into the CBD field. Discussions are already underway with various labs and suppliers of top quality CBD products. You can stay up to date with our progress by visiting our website: http://www.marathonrx.com and subscribing to our newsletter for updates.
About MarathonRx, Inc.
MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry. As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.
About Marathon Group Corp
Marathon Group Corp. (PDPR) is a Connecticut-based software company engaged in web property development, focused on solving problems faced by small and medium size businesses.
Safe Harbor Statement
The matters discussed, particularly information regarding future revenue, earnings, business plans and goals, consist of forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections and involve risks and uncertainties, which could cause actual results to differ materially from the forward-looking information. Such statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management’s assumptions and the Company’s future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially. The Company undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking information contained herein is subject to the risk factors and uncertainties described in the Company’s filings with the Securities and Exchange Commission, which risk factors and uncertainties are incorporated by reference as though fully set forth herein.
MacDonald Tudeme
jasmactt@gmail.com
(0)
(0)